One backer of MDMA therapy sees 'exponential' growth upon FDA approval this year - MarketWatch
marketwatch.comSubmitted by marketwatch5869 in business
Cody Shandraw of Ambria Capital believes the regulator could allow the drug to treat PTSD as soon as August